Can BCG vaccine reduce COVID mortality rate in elderly? Tamil Nadu to launch trial soon

Credit: DNA- Published 3 weeks ago
As ordered by Chief Minister E Palaniswami, the BCG vaccine shall be administered on a trial basis, on adults aged 60-95, with the aim of reducing the COVID mortality rate in this age group, Tamil Nadu Health Minister Dr C Vijayabaskar said.
Advertisement

Video credit: HT Digital Content
Published on July 14, 2020 -  04:32
Covid-19: BCG vaccine can prevent deaths, severe infections
Hindustan Times’ National Political Editor, Sunetra Choudhury brings you the top stories you need to know. Sunetra talks about the number of covid-19 cases in India, study on BCG vaccine, zero death reported from New York on Sunday, study suggests 10 million children may never return to school after pandemic and more.

You are here


πŸ’‘ One News Page Knowledge: Other News Mentions

Coronavirus disease 2019

Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2
Credit: IndiaTimes - Published 42 minutes ago

India crossed the 21-lakh mark in Covid cases on Wednesday on the back of the highest single-day surge in fresh infections β€” crossing the 65,000-mark for the..
Credit: IndiaTimes - Published 3 hours ago

After one week of school, more than 250 students at staff in Cherokee County, Georgia, must quarantine due to potential exposure to COVID-19.
Credit: USATODAY.com - Published 5 hours ago



Related videos from verified sources

Covid update: 2 more ministers infected; plane crash testing; USA schools 04:32
Credit: HT Digital Content - Published 4 hours ago 


'Imagine if Covid struck before 2014': PM Modi inaugurates Swachhata museum 04:58
Credit: HT Digital Content - Published 7 hours ago 


Coronavirus vaccine trial to start next week in Palm Beach County 01:31
Credit: WPTV News | West Palm Beach - Published 1 day ago 


Related news from verified sources

As ordered by Chief Minister E Palaniswami, the BCG vaccine shall be administered on a trial basis, on adults aged 60-95, with the aim of reducing the COVID...
3 weeks ago • DNA

The study will focus on the vaccine’s potential in reducing morbidity due to COVID-19, preventing hospitalisation, and reducing mortality
on July 15, 2020 • Hindu

You might like